![]() |
产地 | 中国 |
品牌 | 爱必信(absin) |
货号 | abs814165 |
用途 | 见爱必信官网 |
英文名称 | 见爱必信官网 |
包装规格 | 10mg,10mg,25mg,25mg,100mg,100mg,200mg,200mg |
纯度 | >98%% |
CAS编号 | 1599477-75-4 |
别名 | GPR120 cpdA;GPR120-IN-1;MDK-77754; MDK 77754;GPR120 Agonist 3 |
是否进口 | 否 |
公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)!
抑制剂描述: 产品名称:GPR120 Compound A 产品别名:见爱必信官网 英文别名:GPR120 Compound A 靶点:GPR120 CAS:1599477-75-4 纯度:>98% 外观:见爱必信官网 保存方法:Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. 描述: GPR120 compound A is an orally available, high-affinity agonist of GPR120 (EC50 = ~0.35 μm) that demonstrates potent selectivity over another lipid-sensing G-protein, GPR40 (FFAR1). 溶解性:DMSO : ≥ 50 mg/mL (123.20 mM) 体外研究:
GPR120-IN-1 is fully selective for Gpr120 (logEC50=−7.62) with negligible activity towards Gpr40. GPR120-IN-1 produces concentration dependent increases in IP3 production from both human and mouse Gpr120 expressing cells. GPR120-IN-1 leads to a concentration-dependent response to recruit β-arrestin-2 in both human and mouse Gpr120 expressing cells, with EC50s of ~0.35 μM. GPR120-IN-1 strongly and comparably inhibits LPS-induced phosphorylation of Tak1, Ikkβ, and Jnk and blocked IκB degradation . 体内研究:GPR120-IN-1 causes improved insulin sensitivity with increased glucose infusion rates, enhanced insulin stimulated-glucose disposal rate, along with a marked increase in the ability of insulin to suppress hepatic glucose production only in WT mice. GPR120-IN-1 treatment has beneficial effects on hepatic lipid metabolism, causing decreased hepatic steatosis, decreased liver triglycerides, and DAGs, along with reduced saturated free fatty acid conten.
产品信息订购:
|